Patent details

EP3160978 Title: GEMCITABINE PRODRUGS

Basic Information

Publication number:
EP3160978
PCT Application Number:
GB2015051857
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157334970
PCT Publication Number:
WO2015198058
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GEMCITABINE PRODRUGS
French Title of Invention:
PRODROGUES DE GEMCITABINE
German Title of Invention:
GEMCITABINE-PRODRUGS
SPC Number:

Dates

Filing date:
25/06/2015
Grant date:
29/07/2020
EP Publication Date:
03/05/2017
PCT Publication Date:
30/12/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/07/2020
EP B1 Publication Date:
29/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/06/2024
Expiration date:
25/06/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/07/2020
 
 

Name:
NuCana plc
Address:
3 Lochside Way, Edinburgh EH12 9DT, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
31/07/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SERPI, Michaela
Address:
United Kingdom (GB)

2

Name:
MCGUIGAN, Christopher
Address:
United Kingdom (GB)

3

Name:
SLUSARCZYK, Magdalena
Address:
United Kingdom (GB)

4

Name:
FERRARI, Valentina
Address:
United Kingdom (GB)

5

Name:
GRIFFITH, Hugh
Address:
United Kingdom (GB)

Priority

1

Priority Number:
2050MU2014
Priority Date:
25/06/2014
Priority Country:
India (IN)

2

Priority Number:
201411253
Priority Date:
25/06/2014
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/7068; A61P 35/00; C07H 19/10;

Publication

European Patent Bulletin

1

Issue number:
202031
Publication date:
29/07/2020
Description:
Grant (B1)

2

Issue number:
202036
Publication date:
02/09/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
02/06/2023
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
IP CENTRUM LIMITED
Filing date Document type Number of pages
31/07/2020 Outgoing Correspondence 1
31/07/2020 Power Of Attorney 1